HIGHLIGHTS OF PRESCRIBING INFORMATION o For patients weighing . . . - Amgen The recommended initial dosage titration from Day 1 to Day 5 is shown in Table 1 Following the 5-day titration with OTEZLA, the recommended maintenance dosage is OTEZLA 30 mg twice daily or OTEZLA XR 75 mg once daily taken orally starting on Day 6 This titration is intended to reduce the gastrointestinal symptoms associated with initial therapy
label - Food and Drug Administration Before using OTEZLA in patients with a history of depression and or suicidal thoughts or behavior, prescribers should carefully weigh the risks and benefits of treatment with OTEZLA in such
Otezla® Prescribing Information to Help Get Your Patients Started View a step-by-step flowchart that illustrates the process to prescribe Otezla® (apremilast) Find information about formulary and health insurance coverage, co-pay and patient support programs, and other resources for HCPs and patients
label - accessdata. fda. gov These highlights do not include all the information needed to use OTEZLA OTEZLA XR safely and effectively See full prescribing information for OTEZLA OTEZLA XR
Otezla (Amgen, Inc): FDA Package Insert OTEZLA is indicated for the treatment of pediatric patients 6 years of age and older and weighing at least 20 kg with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy
FDA Label for Otezla Tablet, Film Coated Oral - NDC List This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients